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ABSTRACT 
Urolithiasis is a multifactorial disease that remains a significant health problem. It carries significant 
morbidity and imposes tremendous financial burden on healthcare system. A variety of intrinsic and 
extrinsic factors influence the incidence of disease. Management of urolithiasis depends on size and 
location of stone. Stone larger than 5 mm, which fails to pass through urinary system, should be treated by 
some interventional procedure such as Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy, 
Percutaneous Nephrolithotomy.  
Unfortunately the propensity for stone recurrence is not altered by removal of stone by these procedures 
and recurrence is still about 50% within 10 years. In addition these interventional procedures show some 
significant side effects. For prevention or recurrence of stone many herbal medicines have been 
traditionally used to treat kidney stones and have been shown to be effective. Acharya Vagbhatta has 
explained in Ashmari Chikitsa adhyaya that intake of lukewarm decoction of root of Moringa oleifera 
(Shigru) have lithotriptic action. Considering the above reference the present study was carried out to 
evaluate lithotriptic action of Moringa oleifera as it is cheap, easily available and palatable. 
Result & Conclusion: This study shows that Shigru Mula Kwath is as effective as compared to Varunadi 
Kwath, also Shigru Mula Kwath significantly helped to reduce the signs, symptoms and help to disintegrate 
the calculus. The prospective aspect of this study reveals that Shigru Mula Kwath can be used as lithotriptic, 
diuretic, alkalizer and analgesic to treat the Ashmari effectively. 
KEYWORDS: Mutrashmari, RCT, Ashmaribhedana, Shigru mula Kwath, Varunadi Kwath. 
INTRODUCTION
Ayurveda, the system of Indian medicine and 
science of life deals with the well being of mankind. The 
three great authors namely Charaka, Sushruta and 
Vagbhata followed the scientific methods of study to 
enhance the perception of Ayurveda towards humanity. 
Mutrashmari is known to mankind since times 
immemorial. Clinical features of the disease are described 
even in Vedas, the oldest repositories of human 
knowledge. Sushruta the “Father of Surgery” explained 
urinary calculus under the heading of Ashmari in details 
including etiological factors[1], classification,[2] 
symptomatology,[3] pathology,[4] complications[5] and its 
management[6] in a most scientific manner. This disease is 
dreadful and hence considered one of the ‘Mahagadas’[7] by 
Sushruta, may be owing to its potentiality to disturb the 
anatomy and physiology of urinary system. 
While going through the Ayurvedic Classics, a 
vivid description is available on the obstructive uropathy 
since ancient time. Their means of management include 
different treatment modalities; medicinal and 
surgical.[9],[10],[11] As surgical modalities have certain 
limitations, risk, complications and high recurrence rate. 
Various drugs are in a trial to prove their efficacy. 
The efficacy of various indigenous drugs referred 
from various classical texts of Ayurveda has also proven; 
by various researches from Ayurvedic Institute and 
Modern Medical Institutions. But the demand for New 
Scientific evidence for the efficacy, safety and quality of its 
medications is gaining momentum; such demands has 
motivated me to launch ambitious research and strengthen 
the principles of Ayurveda. 
 Hence from the various available references a 
Shigru Mula (Moringa oleifera) Kwath described by 
Vagbhata was selected for study.[8] 
Objectives 
1. To evaluate the lithotriptic actions of Shigru Mula 
Kwath (Moringa oleifera) in Urolithiasis. 
2. To compare the lithotriptic action of Shigru with 
Varunadi Kwath. 
3. Comprehensive compilation of action of various herbs 
and compounds acting on Mutravaha Srotas as 
mentioned in various Ayurvedic texts. 
MATERIALS AND METHODS 
Study population 
 The patients were selected from the outpatient 
unit of Govt. Ayurveda College and Hospital Nagpur 
according to inclusion and exclusion criteria. A special 
proforma was prepared in which detail examinations of 
Urolithiasis patients recorded.( as per the ethical guideline 
with informed consent of each and every patient from Yr. 
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2012-2014). They were divided in to two equal groups by 
Lottery method. 
Plan of Work: Patients selected for study, screened into 
two groups-Trial and Control group. 
1)  Group A: Trial Group- The patients were treated with 
Shigru Mula Kwath. 
2)  Group B: Control Group- The patients were treated 
with Varunadi Kwath. 
Sample size 
The present study was an Open Randomized 
control trial. Total 60 patients were selected on the basis 
of selection criteria mentioned above and divided in two 
groups i.e. Trial Group and Control Group, each containing 
30 patients.  
Criteria of selection of patients 
 Patients suffering from urinary calculus measuring 
size 6-15 mm were selected randomly. 
 Patients of age between 15-60 yrs were selected for 
study, and Dose of Medicine was same for the age 
group in trial group A as well as control group B. 
 The patients without any major complication like 
obstructive uropathy renal failure, renal hypertension, 
diabetes mellitus etc. were selected on the basis of 
clinical sign, symptom & pathological as well as 
radiological Investigation. 
 The patient who had either positive radiological 
diagnosis of calculus or significant evidence of crystal 
in urine was selected for the present clinical study. 
Criteria for the rejection of the patient 
The following patients of calculus were excluded from the 
present clinical study.  
 Patient suffering from calculus size more than 15mm, 
6 mm for ureteric calculi. 
 The Patient having major complication like- 
 Renal Failure 
 Renal hypertension 
 Severe hydronephrosis 
 Uraemia 
 Diabetic mellitus 
 Acute retention of urine 
 Patient having severe obstructive uropathy. 
 Patient in critical condition having severe signs & 
symptoms, requiring immediate surgery or intensive 
care.  
The patient with no symptomatic relief within 7 
day of trial treatment were terminated from the study and 
advised for the surgical removal of calculus. 
Treatment plan  
For the evaluation of efficacy of Ashmaribhedan 
compound study was divided into two groups Group A 
(Trial Group) and Group B (Control Group). 
Each group contains 30 patients selected on the 
basis of selection criteria. 
Trial group – Group –A 
Group A was called TRIAL GROUP, for this group the 
special drug i.e. Shigru Mula Kwath containing. 
Kwath of root of Shigru (Moringa oleifera). 
Kwath prepared according to method mentioned in 
Sharangdhar Samhita[12] Madhyam Khand Cha. 2/1-2.  
Drug: Shigrumula kwath  
Dosage form:   Luke warm Kwath 
Dose:    20 ml 
Route of administration: Oral 
Time of administration: Twice a day, before meal 
Duration of therapy:  30 days 
Control group –Group B 
Group B was control group, in this group, the 
patients were treated with Varunadi kwath taken from 
reputed pharmacy. Kwath prepared according to method 
mentioned in Bhaisajya Ratnavali 36/19. 
Drug:  Varunadi Kwath  
Dose:  20 ml 
Route of administration: Oral 
Time of administration: Twice a day, before meal. 
Anupana:  Luke warm water 
Duration of therapy: 30 days 
Criteria of assessment  
The main criteria of assessment in present 
clinical study was based on the symptomatic relief of 
associated symptoms. Apart from above; passing out of 
Ashmari was also taken into consideration. 
Subjective Criteria 
Gradations of symptoms for the assessment were as 
follows: 
Pain  
Grade 0 - Absent 
Grade 1 – Present but does not disturb daily routine. 
Grade 2 – Present and disturbs daily routine. 
Grade 3 - Severe colicky pain due to which patient rolls on 
bed. 
Hematuria  
Grade 0 - Below 4 RBC’S/HPF 
Grade 1 - 5-10 RBC’S/HPF 
Grade 2 - Above 10 RBC’S/HPF 
Grade 3 - Visible by naked eye (pink or red colour urine) 
Dysuria 
Grade 0 - Absent 
Grade 1 - Mild pain during Micturation 
Grade 2 – Moderate pain during Micturation 
Grade 3 - Severe pain during Micturition 
Objective Criteria 
Ultrasonography 
Grade 0 -Negative Finding  
Grade 1 -Positive Finding 
Criteria for assessment of total effect of therapy 
Complete relief  75%-100% relief 
Markedly relieved 50%-75% relief 
Relieved   25%-50% relief 
Unchanged   <25% relief 
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 Two follow ups were carried out on 30th and 60th 
day after completion of treatment. Patient was assessed by 
their symptomatic relief, USG guidance.  
RESULT AND DISCUSSION 
Assessment of parameter Pain 
 The evaluation of effect of therapy by Wilcoxon-
Signed-Rank Test in the above table is suggestive of 
Extremely significant results for the assessment parameter 
PAIN in Group A and Group B as p value (p<0.0001) and 
(p<0.0001) respectively. 
Table 1: Showing Observations on the Basis of 
Wilcoxon-Signed-Rank Test for the Assessment 
Parameter Pain in Group A (Trial Group) and Group B 
(Control Group) 
 Trial Group Control Group 
 BT AT BT AT 
Mean 1.86 0.53 1.86 0.33 
Median 2 1 2 0 
SD 0.43 0.50 0.62 0.47 
Range 1-3 0-1 1-3 0-1 
Z-statistic 4.983 4.932 
p-value <0.0001 <0.0001 
Comparison of Mean change in PAIN 
For examining the significance of intergroup 
differences, further the data is treated by Mann-Whitney 
test. From the table shown below, the Mean difference 
±S.D of assessment parameter Pain in group A and B 
is1.33±0.47and 1.53±0.50 respectively and the p value 
is0.1211, which shows no significant result in both the 
groups. That mean therapies show similar changes in 
respective Groups after the treatment. 
Table 2: Table Showing Comparison of Mean Change in 
PAIN Between Group A (Trial Group) and Group B 
(Control Group) by Mann-Whitney Test. 
 Trial Group Control Group 
Mean change 1.33 1.53 
SD 0.47 0.50 
Z-statistic 1.550 
p-value 0.1211 
Assessment of Parameter Dysuria 
The evaluation of effect of therapy by Wilcoxon-
Signed-Rank Test in the table below is suggestive of 
extremely significant results for the assessment parameter 
dysuria in Group A and Group B as p value is less than 
0.0001 in both groups. 
Table 3: Showing Observations Based on Wilcoxon-Signed-
Rank Test for the Assessment Parameter Dysuriaof Group A 
(Trial Group) and Group B (Control Group) 
 Trial Group Control Group 
 BT AT BT AT 
Mean 1.5 0.5 1.53 0.36 
Median 1.5 0.5 2 0 
SD 0.50 0.50 0.68 0.49 
Range 1-2 0-1 0-2 0-1 
Z-statistic 5.170 4.808 
p-value <0.0001, HS <0.0001, HS 
 
 
Comparison of Mean Change in Dysuria 
From the table below, the Mean difference ±S.D of 
assessment parameter Dysuria in group A and B 
is1±0.37and 1.16±0.64 respectively and the p value 
is0.1905, which shows not significant result in both the 
groups. That mean therapies show similar changes in 
respective Groups after the treatment. 
Table 4: Showing Comparison of Mean Change in 
Dysuria in between Group A (Trial Group) and Group B 
(Control Group) by Mann-Whitney test. 
 Trial Group Control Group 
Mean change 1 1.16 
SD 0.37 0.64 
Z-statistic 1.309 
p-value 0.1905 
Assessment parameter HAEMATURIA 
The evaluation of effect of therapy by Wilcoxon-
Signed-Rank Test in the table shown below is suggestive of 
extremely significant results for the assessment parameter 
haematuria in Group A and Group B as p value (p<0.0001) 
in both groups. 
Table 5: Showing Observations of Wilcoxon-Signed-
Rank Test for the Assessment Parameter Haematuria 
of Group A (Trial Group) and Group B (Control Group) 
 Trial Group Control Group 
 BT AT BT AT 
Mean 1.03 0.13 0.86 0 
Median 1 0 1 0 
SD 0.76 0.34 0.77 0 
Range 0-2 0-1 0-2 0 
Z-statistic 4.459 4.259 
p-value <0.0001, HS <0.0001, HS 
Comparison of Mean change in Haematuria 
From the table below, the Mean difference ±S.D of 
assessment parameter haematuria in group A and B 
is0.90±0.71and 0.86±0.77 respectively and the p value 
is0.1905, which shows not significant result in both the 
groups. That mean therapies show similar changes in 
respective Groups after the treatment. 
Table 6: Showing Comparison of Mean Change in 
Haematuria in Between Group A (Trial Group) and 
Group B (Control Group) by Mann-Whitney test. 
 Trial Group Control Group 
Mean change 0.90 0.86 
SD 0.71 0.77 
Z-statistic 0.215 
p-value 0.8298,NS 
Assessment of U.S.G. findings 
1. Assessment of Parameter Positive/Negative U.S.G. 
Finding Related with Lithotriptic Action 
 In Group A of 30 patients 27 (90%) patients are 
having Positive U.S.G. finding i.e. cured by therapy. While 
03(10%) patients are having no change in U.S.G. finding. 
Hence percentage of relief is 90%. In Group B of 30 
patients 12 (40%) patients are having Positive U.S.G. 
finding i.e. cured by therapy. While 18(60%) patients are 
having no change, hence percentage of relief is only 40%. 
For examining the significance of intergroup differences, 
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the data is treated by Chai-square test. From the table 
below, at 1 degree of freedom chai-square value 16.48, is 
highly significant (P<0.001). That mean therapy in Group A 
is having better lithotriptic action as compare to the 
therapy in Group B. 
Table 7: Showing Observations on the Basis of CHAI-SQUARE 
TEST for the Assessment Parameter Positive/Negative U.S.G. 
Finding Related with Lithotriptic Action in Group A (Trial 
Group) and Group B (Control Group) 
Change Trial Group Control Group 
Positive 27 (90) 12 (40) 
No change 3 (10) 18 (60) 
Chi2 value 16.48  
p-value <0.001, HS  
2. Assessment of Parameter Size of Calculus 
The evaluation of effect of therapy by Pair t test in 
the above table is suggestive of Extremely significant 
results for the assessment parameter Size of calculus in 
Group A and Group B as p value (p<0.0001) in both groups. 
Table 8: Table Showing Observations on the Basis of Pair-t 
Test for the Assessment Parameter Size of Calculus in Group 
A (Trial Group) and Group B (Control Group) 
 Trial Group Control Group 
 BT AT BT AT 
Mean 7.44 1.91 7.62 3.01 
Median 7 2 7.55 3 
SD 1.24 1.75 1.33 1.31 
Range 6-10 0-5 6-10 0-5.5 
Z-statistic 4.796 4.788 
p-value <0.0001 <0.0001, HS 
Comparison of Mean change in size of calculus 
From the table below, the Mean difference ±S.D of 
assessment parameter size of calculus in group A and B 
is5.52±0.95and 4.61±1.05 respectively and the p value 
is0.0008, which shows highly significant result. That 
means therapy in Group A show better effect on reducing 
the size of stone as compare to therapy in Group B. 
Table 9: Table Showing Comparison of Mean change in 
Size of Calculus in Between Group A (Trial Group) and 
Group B (Control Group) by Unpair-t test 
 Trial Group Control Group 
Mean change 5.52 4.61 
SD 0.95 1.05 
Z-statistic 3.339 
p-value 0.0008 
Total effect of therapy  
In Group-A, out of 30 patient suffering from 
urolithiasis of 06 (20%) patients got complete relief, 21 
(70%) patients were Markedly Relieved, 3 (10%) patient 
was Relieved and no patient is recorded as Unchanged. 
In Group–B of 30 patients. 5 (16.67%) got 
Complete relief, 22 (73.33%) patient were Markedly 
Relieved, 03 (10%) patients Relieved and no patient was 
recorded as Unchanged. 
This shows that Group–A and Group-B had almost similar 
overall effect of therapy but therapy in Group A had better 
lithotropic action as compare to therapy in Group B. 
Graph-1 showing observations of Total Effect Of Therapy 
 
 
 
 
 
 
   
 Thus from all discussion regarding the research 
work and mode of action of drug it can be concluded, that 
the Shigru Mula Kwath possesses stone dissolving 
(Ashmarichedanam), anti-infective, antiseptic (Mutrarakta-
shodhana), diuretic (Mutral) and antispasmodic properties 
(Mutrakrichapranashan). 
The present clinical study reveals that Shigru Mula 
Kwath is useful in urinary symptoms and has a lithotriptic 
action. 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
From overall study and statistical analysis, it is 
obvious that Shigru Mula Kwath is as effective as Varunadi 
Kwath in relieving symptoms of Urolithiasis like pain, 
Heamaturia and Dysuria but the effect of Shigru mula 
Kwath on reduction in size of calculus and on U.S.G. finding 
related Ashmari bhedana (lithotriptic action) were found 
to be more effective as compare to Varunadi Kwath. Shigru 
mula Kwath is effective in relieving Pain, Heamaturia and 
Dysuria due to its Mutrakrichapranashan, Mutral, Mutra-
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raktashodhana and Mutraghathar property. No significant 
complications or side effect of Shigru Mula Kwath is 
observed during the treatment. Pain was the first symptom 
which reduced very fast during the treatment by 
administration of Shigru Mula Kwath. 
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